Human vaccines & immunotherapeutics: News November 2022
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2155378 |
| _version_ | 1797673080362893312 |
|---|---|
| author | Ronald Ellis Adam Weiss |
| author_facet | Ronald Ellis Adam Weiss |
| author_sort | Ronald Ellis |
| collection | DOAJ |
| first_indexed | 2024-03-11T21:39:23Z |
| format | Article |
| id | doaj.art-0850f9f2be2b4b069686a830ebb06f49 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:39:23Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-0850f9f2be2b4b069686a830ebb06f492023-09-26T13:25:46ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-12-0118710.1080/21645515.2022.21553782155378Human vaccines & immunotherapeutics: News November 2022Ronald Ellis0Adam Weiss1Editor-in-Chief, Biotech & BiopharmaAcquisitions Editor, Taylor & Francis Grouphttp://dx.doi.org/10.1080/21645515.2022.2155378 |
| spellingShingle | Ronald Ellis Adam Weiss Human vaccines & immunotherapeutics: News November 2022 Human Vaccines & Immunotherapeutics |
| title | Human vaccines & immunotherapeutics: News November 2022 |
| title_full | Human vaccines & immunotherapeutics: News November 2022 |
| title_fullStr | Human vaccines & immunotherapeutics: News November 2022 |
| title_full_unstemmed | Human vaccines & immunotherapeutics: News November 2022 |
| title_short | Human vaccines & immunotherapeutics: News November 2022 |
| title_sort | human vaccines immunotherapeutics news november 2022 |
| url | http://dx.doi.org/10.1080/21645515.2022.2155378 |
| work_keys_str_mv | AT ronaldellis humanvaccinesimmunotherapeuticsnewsnovember2022 AT adamweiss humanvaccinesimmunotherapeuticsnewsnovember2022 |